Skip to main content
TipRanks
Go Ultimate75% OFF

Ron Cohen Insider Profile

4 Followers

Ron Cohen, former President & CEO, Director at Acorda Therapeutics, holds 149.76K shares in Acorda Therapeutics (Ticker: ACORQ), holds 0.00 shares in Dyax Corp (Ticker: DYAX). Most recently, Ron Cohen Bought ― shares of Acorda Therapeutics on Mar 20, 2023 for an estimated value of $12.59K.

Ron Cohen's Trading History

ACORQ
Acorda Therapeutics
Mar 20, 2023―Informative Buy12.59K$1.95K
DYAX
Dyax Corp
Jan 22, 2016―Uninformative Sell―$0.00

You May Also Like

Ron Cohen insider profile FAQ

What is the percentage of profitable transactions made by Ron Cohen?
The percentage of profitable transactions made by Ron Cohen is 100%.
What is the average return per transaction made by Ron Cohen?
The average return per transaction made by Ron Cohen is 44.60%.
What stocks does Ron Cohen hold?
Ron Cohen holds: ACORQ, DYAX stocks.
What was Ron Cohen’s latest transaction?
Ron Cohen’s latest transaction was an Informative Buy of $12.59K.
What was Ron Cohen's most profitable transaction?
Ron Cohen’s most profitable transaction was an Informative Buy of ACORQ stock on June 20, 2017. The return on the trade was 68.00%.
What is Ron Cohen's role in Acorda Therapeutics?
Ron Cohen's role in Acorda Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.